Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia

(2018) Mark A. Schroeder et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease

(2018) John M. Magenau et al.   BLOOD

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

(2018) Hannah Major-Monfried et al.   BLOOD

Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review

(2018) Yngvar Fløisand et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

(2017) Robert Zeiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients

(2016) Nicola Polverelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

(2016) Andrew C. Harris et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors

(2016) Aleksandr Lazaryan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD

(2016) Gérard Socié et al.   BLOOD

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

(2016) I García-Cadenas et al.   BONE MARROW TRANSPLANTATION

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

(2015) R Zeiser et al.   LEUKEMIA

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

(2014) S. Spoerl et al.   BLOOD

Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis

(2013) Madan Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

(2013) Y. Inamoto et al.   HAEMATOLOGICA

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

(2012) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment

(2011) Aliénor Xhaard et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk factors for acute GVHD and survival after hematopoietic cell transplantation

(2011) M. Jagasia et al.   BLOOD

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease

(2009) Joseph Pidala et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement

(2009) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION